drugset / Trial / NCT02828319
Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia
NaSingle-groupOpen-labelTreatment
Summary
To confirm the safety and efficacy of Z-213 until 12 weeks after start of Z-213 administration in patients with iron deficiency Anemia
Timeline
- Start
- 2016-07
- Primary completion
- 2017-05
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Z-213 | Unknown | — | Intravenous |